Translate this page into:
Beyond emollients: A review of moisturizers in dermatology
*Corresponding author: Amitta Rachel Santhosh, Department of Dermatology, Venereology and Leprosy, Government Medical College, Kottayam, Kerala, India. amittarachel@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Santhosh AR, Vineetha M, Ajithkumar K. Beyond emollients: A review of moisturizers in dermatology. J Skin Sex Transm Dis. doi: 10.25259/JSSTD_143_2025
Abstract
Moisturizers are an integral part of dermatological care, functioning as adjuncts in a wide range of inflammatory, xerotic, and keratinization disorders. Beyond symptomatic relief, advances in moisturizer formulations have established their role in skin barrier repair and disease prevention. They have evolved from passive emollients to biologically active adjunctive therapies, with evidence supporting their use across diverse dermatological conditions. Moisturizers are broadly classified into emollients, occlusive, humectants, and protein rejuvenators, each with distinct mechanisms and clinical indications. Dispensing formulations determine bioavailability, acceptability, and adherence with selection tailored to disease severity, anatomical site, and patient preference. This review offers an in-depth overview of current evidence on moisturizers, including their significance, recent advancements, and safety considerations. Individualized selection increases therapeutic benefit. Continued advances in barrier science and targeted delivery will further refine their role in precision dermatology.
Keywords
Atopic dermatitis
Barrier repair
Emollients
Ichthyotic disorders
Moisturizers
INTRODUCTION
The integrity of the epidermal barrier is central to cutaneous homeostasis and overall skin health. Disruption of the stratum corneum barrier is a common pathogenic denominator in several dermatological conditions. Restoration and maintenance of this barrier is a fundamental therapeutic goal in dermatology practice. Moisturizers, once regarded primarily as cosmetic agents, are now recognized as an essential therapy component. It plays a vital role in skin hydration, softness, and overall skin health. Over the past two decades, moisturizer formulations have evolved considerably, incorporating physiologic lipids, ceramides, natural moisturizing factors (NMFs), and novel delivery systems aimed at mimicking or restoring normal barrier architecture. With countless options available today, choosing the right moisturizer can be overwhelming.
Despite the widespread use of moisturizers, the existing literature remains fragmented, often limited to disease-specific applications. There is a scarcity of comprehensive, clinically oriented reviews that integrate formulation science with evidence-based practice. This article begins by reviewing the role of moisturizers in skin barrier maintenance, and then it discusses the type of moisturizers and their dispensing formulations, the choice of moisturizers to be used, the method of application, and therapeutic moisturizers. It also mentions the newer additives to moisturizer components while explaining the adverse effects moisturizers can cause. This review aims to comprehend current knowledge on moisturizers and to provide a rational framework for their use in everyday dermatology.
ROLE OF MOISTURIZER IN SKIN BARRIER MAINTENANCE
Among the many functions of the skin, one important function is the barrier function, the failure of which leads to increased transepidermal water loss and various dermatitis.
Stratum corneum is an active membrane explained by the Brick and Mortar model [Figure 1], where stratum corneum corneocytes with a resistant envelope and keratin microfibrils are the bricks, while the layers of lipid between the cells are the mortar.[1] The main barrier to water loss is the lipid mortar. A key difference between the current and the earliest version of the model is the understanding that the bricks are now known to be connected by desmosomes. Desmosomes are glycoproteins that connect corneocytes. Corneodesmosin is an additional protein in the desmosomes joining stratum corneum corneocytes when compared to other keratinocytes of the epidermis.[2] Thus, they are sometimes referred to as corneodesmosomes.

- A “Bricks and Mortar” model for human stratum corneum illustrating the corneocyte “Bricks,” the Intercellular lipid “Mortar,” and the desmosomes connecting the corneocytes.
The lamellar bodies formed at the stratum granulosum contain lipids, which are released to the intercellular space as the stratum corneum forms. These lipids essentially contain ceramides, cholesterol, cholesterol esters, and long-chain fatty acids. These lipids form the mortar and are critical for the barrier function of the skin.
Water from the deeper epidermal layers moves upward to hydrate stratum corneum cells and is then lost to evaporation. The pivotal factor in skin water flux, retention, and overall moisturizing level is the structure of the stratum corneum. There are four key processes in stratum corneum formation and functioning: corneocyte, stratum corneum lipid, NMF, and desquamation.[3] Corneocytes are the physical barrier of the stratum corneum, contributing to elasticity when hydrated. The lipid bilayer is the mechanical barrier, allowing entry of most topically applied medications despite preventing many chemical entries. The NMF is a mix of hygroscopic molecules maintaining corneocyte hydration. In desquamation, corneodesmosomes are degraded by water-dependent hydrolytic agents, which work less efficiently in the low-moisture stratum corneum. Thus, lessened moisture content leads to the accumulation of corneocytes, and dry skin appears.[4,5] Stated more simply, dry skin occurrence is due to[6] (i) abnormalities of intercellular lipids of the stratum corneum, (ii) lack of NMFs, and (iii) abnormal desquamation of the stratum corneum.
Moisturizers suppress moisture loss from the stratum corneum and supply moisture to the dry skin after application. The skin barrier restoration through moisturizers works in a four-step process: [6] (1) the oily component of the moisturizer creates a thin film on the skin, and barrier repair begins; (2) the skin moisture distribution coefficient changes; (3) moisture diffuses from the dermis to the epidermis; (4) water distribution to the epidermis is controlled by the synthesis of skin lipids and intercellular lipid secretion. That is, the oily component of the moisturizer forms a film on the skin to prevent the evaporation of moisture, the humectant component directly supplies moisture to the epidermis and dermis, and the emollient component controls the exfoliation of dead skin cells to restore the skin barrier.[6] In addition, when components similar to lipids in the stratum corneum of the skin are included in the moisturizer, the lipid component is supplied to the keratinocytes of the epidermis to rearrange the intercellular lipids, thereby maintaining the moisture content in the epidermis and improving the function of the skin barrier.[7,8]
Thus, moisturizers increase stratum corneum water content and improve skin hydration; they smooth skin surface by filling the spaces between the partially desquamated skin and restore the ability of stratum corneum intercellular lipids to absorb, retain, and redistribute water. They also cause the degradation of corneodesmosomes and prevent the accumulation of corneocytes.[5]
TYPES OF MOISTURIZERS AND THEIR DISPENSING FORMULATIONS
Moisturizers can be emollients, humectants, occlusives, and protein rejuvenators [Table 1].[5,6]
| Emollients | Humectants | Occlusives | Protein rejuvenators | |
|---|---|---|---|---|
| Mechanism of action | Saturated and unsaturated hydrocarbons of variable length fill the gaps in stratum corneum (SC). Improves skin barrier function, membrane fluidity and cell signaling. Enhance the skin texture and appearance. | Low molecular substances that attract water from the atmosphere and the deeper layers to the stratum corneum. Because transepidermal water loss can increase when a humectant is applied alone, humectants are usually used together with an occlusive agent | Waxes and oils form an inactive layer over the skin blocking water evaporation from the skin (trans epidermal water loss) | Small molecular weight proteins that replenish essential proteins of skin, thus aiding in skin rejuvenation |
| Examples | Alcohol: cetyl alcohol, stearyl alcohol, isopropyl alcohol, ethyl alcohol. Ester: octyl stearate, isopropyl myristate, oleyl oleate, petroleum jelly, mineral oil and PEG-7 glyceryl cocoate. |
Glycerin, urea, lactate, pyrrolidine carboxylic acid, alpha hydroxy acid, polypeptide, hyaluronic acid, sorbitol, collagen, and elastin | Mineral oil, beeswax, petroleum jelly, silicones, zinc oxide | Collagen, elastin, keratin |
Emollients are substances that primarily focus on softening and smoothing the skin by filling gaps between skin cells with lipids, which contain fat. This action helps to improve the skin’s texture, elasticity, and reduce roughness and flaking without altering the transepidermal water loss (TEWL).[9]
Humectants are hydrophilic substances that attract and bind water from the dermis into the stratum corneum or from the environment under humid conditions. They maintain skin hydration by increasing water content in the outer skin layers, but require an occlusive or adequate ambient humidity to prevent net water loss.[9,10] Occlusives are hydrophobic agents that form a barrier over the skin surface to inhibit TEWL by creating a physical film, thus sealing moisture within the stratum corneum. They are most effective when applied over damp skin or combined with humectants.[9]
Protein rejuvenators are agents that aim to restore or mimic the protein structure and function of skin’s NMFs or structural proteins such as keratin and filaggrin. They may enhance hydration, improve elasticity, and aid in the repair of the epidermal barrier by replenishing amino acids or polypeptides lost in dry or damaged skin.[10]
Depending on the dispensing medium, moisturizers can be of different formulations. Emulsifiers stabilize moisturizers. Cosmetic emulsion is the predominant form of delivery, while a kinetically stabilized colloidal suspension of immiscible liquids is the other form.[11] There is no discernible phase distinction between the two phases. Water is the most essential and commonly used raw material in moisturizer formulations. The moisturizer category and its formulation characteristics are given in Table 2.[10-12]
| Moisturizer category | Formulation characteristics |
|---|---|
| Lotion | Thinner film, O/W emulsion |
| Cream | Thicker film, O/W or W/O emulsion |
| Ointment | Thickest film, no water |
| Powder | Blended small particle solid materials |
| Paste | Powder in ointment |
| Suspension | Powder in water |
| Aerosol | Droplet film |
O/W: Oil-in-Water, W/O: Water-in-Oil.
CHOICE OF MOISTURISER
When choosing a formulation, skin type is the most critical factor (dry, oily, normal, and combination are the selection criteria). For dry skin, select an ointment or oily cream formulation, and for oily skin, choose a lotion- and water-based cream formulation.[6] The body part to be used is also a consideration. For hands, feet, shins, and lips, which are prone to dry skin due to their small number of sebaceous glands, an ointment or cream formulation containing a large amount of occlusive agents should be selected.[5] In fact, it is less preferred to use ointments while lotion, gel, and serum formulations are more preferred.[12] Powder and suspension forms of moisturizers are better used in intertriginous areas.[10] In addition, it is preferable to use a moisturizer-oriented product in summer and an oil-based cream formulation containing large amounts of occlusive agents in winter.[6] The choice of moisturizer also necessitates the consideration of its contraindications. It should be avoided in actively oozing lesions or clinically infected skin, as they delay healing and exacerbate infection. Acne-prone skin warrants the use of non-comedogenic, water-based lotion formulations to minimize follicular occlusion and thereby acne flare. Patients with sensitive skin syndrome benefit from hypoallergenic, fragrance-free preparations.
METHODS OF MOISTURIZER APPLICATION
The efficacy of moisturizers significantly depends on appropriate timing and technique. While humectants and hydrophilic formulations function by attracting moisture from the atmosphere or deeper skin layers, occlusive agents are best applied to damp skin immediately following bathing or showering. After warming the product between the palms, it should be gently applied in the direction of hair growth.
To minimize the risk of oil folliculitis caused by excessive friction, patients should receive clear instructions on proper application methods. The distribution of moisturizers is influenced by the formulation of the vehicle.[5] High-viscosity ointments tend to provide more uniform coverage than lower-viscosity or volatile preparations. Transfer of active ingredients to external surfaces is more pronounced in creams and ointments compared to lotions or tinctures. Post-application, active compounds may remain on the skin, be absorbed, metabolized, or lost through evaporation, desquamation, or physical contact. Studies indicate that only about 50% of the moisturizer remains on the skin surface 8 h after application.[5] Consequently, application frequency should be tailored to the severity of skin dryness, typically ranging from 1 to 3 times daily.
THERAPEUTIC USES OF MOISTURIZERS
Moisturizers are as important for routine skin care as they are for managing skin conditions with a weakened skin barrier or in cases of dry skin. The ideal moisturizer should have the wetting function of NMFs, the sealing function of the skin lipid membrane, and the barrier function of the lipid between keratinocytes.[13] They serve a key supporting role in treating skin disorders such as atopic dermatitis, psoriasis, contact dermatitis, and other eczemas.
Atopic dermatitis
Atopic dermatitis marks a chronic inflammatory disease with skin barrier dysfunction playing the most significant role in pathogenesis. This is contributed by the genetic mutation in the protein filaggrin responsible for maintaining the structural integrity of the epidermal barrier, causing increased trans-epidermal water loss, facilitating exposure of environmental allergens and infective organisms to the skin, leading to chronic inflammatory response.
Management of atopic dermatitis involves treatment and prevention of flares by effective patient counseling and caregiver partnership, as long-term skin barrier restoration is warranted. Evidence indicates that moisturizers are the basic and most important skin treatment in the management of atopic dermatitis, while components of moisturizers need to be carefully considered as they are more prone to contact dermatitis than the normal population.[14,15] Natural oils are widely used as moisturizing agents in atopic dermatitis, and their linoleic acid to oleic acid concentration determines the skin-hydrating and protective effects. In 2005, a randomized control trial in preterm infants concluded that high linoleic acid concentrations can accelerate skin barrier repair and development, improve skin hydration, and ameliorate atopic dermatitis severity, making them perfect for steroid sparing.[16] Safflower oil and sunflower seed oil are natural oils with the highest linoleic acid: oleic acid ratios.[17]
However, olive oil has a relatively low linoleic: Oleic acid ratio, which can significantly deteriorate the skin barrier and homeostasis.[16] Humectants, alpha-hydroxy acids, and ceramides are other components used in moisturizers to enhance the barrier function. However, there are conflicting findings in the primary prevention of atopic dermatitis and the practice of regular moisturization. Protective effect of daily moisturizer on atopic dermatitis with a relative risk reduction of 50% and 32% are reported by Simpson et al.[18] and Horimukai et al.[19] respectively, while the randomized controlled trial (the barrier enhancement for eczema prevention [BEEP] study) could not find any significant preventive effect.[20] Kritsanaviparkporn et al., in their systematic review and meta-analysis of RCTs, favor the efficacy of regular moisturization in pediatric patients with atopic dermatitis and extending the flare-free period in children.[21]
Psoriasis
Psoriatic lesions show increased trans-epidermal water loss value when compared to uninvolved skin. Moisturizer application improves skin hydration and supports the function of cadherins and tight junctions, leading to more contact between the epidermal keratinocytes. According to the contact inhibition theory, it hinders hyperproliferation and thickening of the epidermis. Moreover, the use of moisturizers such as mineral oil before phototherapy can reduce the reflectivity of dead cells in thick psoriatic skin.[6]
Nummular dermatitis
Nummular eczema is strongly linked to epidermal barrier disruption, often associated with reduced ceramide levels and increased TEWL, even in non-lesional skin. In a comparative study, 20% urea cream was found to improve xerosis and pruritus scores significantly in chronic eczema patients, highlighting its descaling and humectant effects.[22] Van Zuuren et al., in a Cochrane review of 77 studies on emollients and moisturizers on eczema, stated that long-term use of emollients has also demonstrated a steroid-sparing effect, reducing relapse rates and flare severity.[23]
Contact dermatitis
Contact dermatitis is a common skin inflammation characterized by pruritic and erythematous skin lesions induced by contact with foreign substances, which can be allergic or irritant in type. The American Academy of Allergy, Asthma, and Immunology practice parameter emphasizes avoidance of the invoking agent as the primary prevention in contact dermatitis, while secondary prevention focuses on barrier protection and symptom control.[24] Frequent moisturizer application provides protection and strengthens the skin barrier function. Evidence suggests that lipid-rich moisturizers are recommended and ointments are preferred over creams.[25]
Acne
Acne is a chronic inflammatory disease of the pilosebaceous unit. There are different modalities of treatment for acne with different mechanisms of action; they target the four aspects of acne pathology: Follicular hyperkeratinization, increased sebum production, Cutibacterium acnes proliferation, and inflammation. Topical and systemic therapies for acne can cause skin irritation, dryness, and cheilitis, thereby compromising patient compliance. Increased transepidermal water loss due to skin barrier disruption and inflammation occurs secondary to skin irritation and dryness. Thus, concomitant use of moisturizers can enhance efficacy and alleviate dryness.[26] Salicylic acid at a concentration less than or equal to 2% is often added to moisturizers for its comedolytic property and anti-inflammatory capability by affecting the arachidonic acid cascade, as evidenced by a prospective comparative clinical trial.[27] Silicone derivatives such as dimethicone and cyclomethicone are used in oil-free facial moisturizers.[28] Dimethicone has emollient and occlusive properties, reducing TEWL while being noncomedogenic and hypoallergenic. Cyclomethicone is a thicker silicone with similar properties. Glycerine is the humectant added to increase the hydration of the stratum corneum. However, when used alone, it may increase the TEWL and hence needs to be added with an occlusive like dimethicone.[29] Furthermore, mineral oils of cosmetic grade are found to be less comedogenic than those of industrial grade.[27,28]
Ichthyotic disorders
Ichthyoses are a group of disorders characterized by abnormal epidermal differentiation and barrier dysfunction. Regular and targeted use of moisturizers forms the cornerstone of management, thus aiming to restore hydration, reduce scaling, and improve barrier function. In neonates, pure emollients are preferred as the resorption of topical substances is proportionately high due to a higher ratio of body surface area to weight than in adults.[30,31] In addition, skin is sensitive, and most keratolytics are not tolerated. Urea, the classic humectant, is the active agent in ichthyosis treatment, but is not used below the first year due to irritation and elevated blood levels. Salicylic acid is an effective keratolytic, but it is used in older children and adults to treat limited, stubborn areas.[31] For treating mild-to-moderate ichthyotic disorders, the options include daily application of 2–10% urea, 5–15% lactic acid, 10– 25% propylene glycol, or glycolic acid.[32] The treatment of severe disease requires modulators of differentiation such as retinoids and calcipotriol, in addition to the above keratolytics.[30]
THE NEW ERA OF MOISTURIZERS
The modern use of moisturizers, apart from the traditional functions, targets dampening the immune response and restoring the microbial balance. Newer moisturizer contents include endocannabinoids, anti-inflammatory agents, antioxidants, bioactive lipids, and microbiome modulators.[33] Cutaneous cannabinoid dysregulation leads to chronic inflammatory conditions of the skin, while endocannabinoids and bioactive lipids are increasingly being used in moisturizers for restoring skin homeostasis.[34] They serve as a steroid-sparing alternative, mitigating itch and inflammation in eczematous dermatoses.[33]
Recently, aloe vera (anti-inflammatory, anti-pruritic, analgesic, and wound healing properties[35]), bisabolol (anti-inflammatory and antipruritic properties[36]), shea butter (anti-inflammatory and anti-tumor promoting effects[37]), and glycyrrhetinic acid (anti-inflammatory, antiviral and antitumor effects[38]) are additions to moisturizer contents along with niacinamide and zinc gluconate to enhance the efficacy. Inflammatory dermatoses are associated with altered microbial composition of skin, and microbial restoration can be done using moisturizers.[39]
Surface microbial restoration can be in the form of prebiotics, probiotics, parabiotics, and postbiotics, and are believed to increase regulatory T-cell response with subsequent suppression of Th2 and Th17- mediated immune responses.[40] Lactobacillus brevis or Lactobacillus sake containing moisturizers resulted in decreased TEWL, xerosis, and pruritus.[41,42] Studies with Bifidobacterium longum lysate cream and Roseomonas mucosa solution have also reported reduced skin sensitivity and decreased severity of inflammatory dermatoses, and atopic dermatitis in particular.[43] Thus, the shift from traditional moisturizers to those with newer inclusions opens a realm of possible therapeutic options for patients with barrier-defective cutaneous conditions.
ADVERSE EFFECTS OF MOISTURIZERS
Although moisturizers offer numerous benefits, they are not devoid of adverse effects. Skin irritation is the most common adverse effect, while allergic contact dermatitis, photocontact dermatitis, and occlusive folliculitis are a few others. The adverse effects of moisturizers with their plausible causes are listed in Table 3.[44]
| Adverse effect | Plausible ingredients |
|---|---|
| Skin irritation | Humectants, preservatives like benzoic acid, sorbic acid and proteins in vegetable oils, propylene glycol |
| Allergic contact dermatitis | Lanolin, propylene glycol, preservatives, fragrances, sunscreen, aloe Vera, olive oil |
| Occlusive folliculitis | Petrolatum, mineral oil |
| Photocontact dermatitis | Fragrances, preservatives, hydroxyl oils |
| Cosmetic acne | Occlusive oils |
| Contact urticaria | Fragrances, preservatives, sorbic acid, balsam of Peru |
| Intoxication | Salicylic acid |
CONCLUSION
Moisturizers play a vital role in maintaining skin hydration, enhancing barrier function, and improving overall skin health. With a wide range of formulations tailored to different skin types and conditions, they offer substantial benefits in both cosmetic and therapeutic contexts but are not exempt from risks. Optimal moisturizer selection based on individual needs and ingredient compatibility is essential for maximizing benefits and minimizing adverse effects. Despite their widespread prescription, evidence remains heterogeneous with limited comparative and long-term clinical data. Future studies addressing formulation-specific efficacy and standardized outcomes are needed to enable more precise recommendations.
Ethical approval:
Institutional Review Board approval is not required.
Declaration of patient consent:
Patient’s consent not required as there are no patients in this study.
Conflicts of interest:
Dr. Mary Vineetha and Dr. Kidangazhiathmana Ajithkumar are on the Editorial Board of the Journal.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript, and no images were manipulated using AI.
Financial support and sponsorship: Nil.
References
- The intercorneocyte space In: Marks R. Plewig G, editors. Stratum Corneum. New York: Springer-Verlag; 1983. p. :53-67.
- [CrossRef] [PubMed] [Google Scholar]
- Corneodesmosin, a component of epidermal corneocyte desmosomes, displays homophilic adhesive properties. J Biol Chem. 2002;277:5024-9.
- [CrossRef] [PubMed] [Google Scholar]
- Cosmeceuticals: Function and the skin barrier In: Draelos ZD, ed. Procedures in Cosmetic Dermatology Series: Cosmeceuticals (1st ed). Philadelphia, PA: Elsevier; 2005. p. :97-102.
- [Google Scholar]
- The role of moisturizers in addressing various kinds of dermatitis: A review. Clin Med Res. 2017;15:75-87.
- [CrossRef] [PubMed] [Google Scholar]
- Moisturizer in patients with inflammatory skin diseases. Medicina (Kaunas). 2022;58:888.
- [CrossRef] [PubMed] [Google Scholar]
- The management of dry skin with topical emollients--recent perspectives. J Dtsch Dermatol Ges. 2005;3:768-74.
- [CrossRef] [PubMed] [Google Scholar]
- Limonoids and unsaturated fatty acids present in Melia toosendan increase ceramide production in keratinocytes. Fitoterapia. 2021;155:105058.
- [CrossRef] [PubMed] [Google Scholar]
- The science behind skin care: Moisturizers. J Cosmet Dermatol. 2018;17:138-44.
- [CrossRef] [Google Scholar]
- A review of moisturizers; history, preparation, characterization and applications. Cosmetics. 2022;9:61.
- [CrossRef] [Google Scholar]
- The skin health and beauty pyramid: A clinically based guide to selecting topical skincare products. J Drugs Dermatol. 2014;13:414-21.
- [Google Scholar]
- Increased 1-deoxysphingolipids and skin barrier dysfunction in the skin of X-ray or ultraviolet B irradiation and atopic dermatitis lesion could be prevented by moisturizer with physiological lipid mixture. Ann Dermatol. 2020;32:306-18.
- [CrossRef] [PubMed] [Google Scholar]
- New concept of the pathogenesis of atopic dermatitis: Interplay among the barrier, allergy, and pruritus as a trinity. J Dermatol Sci. 2013;70:3-11.
- [CrossRef] [PubMed] [Google Scholar]
- Consensus guidelines for the management of atopic dermatitis: An Asia-Pacific perspective. J Dermatol. 2013;40:160-71.
- [CrossRef] [PubMed] [Google Scholar]
- Effect of topical treatment with skin barrier-enhancing emollients on nosocomial infections in preterm infants in Bangladesh: A randomised controlled trial. Lancet. 2005;365:1039-45.
- [CrossRef] [PubMed] [Google Scholar]
- Effect of olive and sunflower seed oil on the adult skin barrier: Implications for neonatal skin care. Pediatr Dermatol. 2013;30:42-50.
- [CrossRef] [PubMed] [Google Scholar]
- Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014;134:818-23.
- [CrossRef] [PubMed] [Google Scholar]
- Application of moisturizer to neonates prevents development of atopic dermatitis. J Allergy Clin Immunol. 2014;134:824-30.e6.
- [CrossRef] [PubMed] [Google Scholar]
- Daily emollient during infancy for prevention of eczema: The BEEP randomised controlled trial. Lancet. 2020;395:962-72.
- [CrossRef] [PubMed] [Google Scholar]
- Efficacy of moisturizers in paediatric atopic dermatitis: A systematic review and meta-analysis of randomised controlled trials. Indian J Dermatol Venereol Leprol. 2021;88:22-31.
- [CrossRef] [PubMed] [Google Scholar]
- The clinical benefit of moisturizers. J Eur Acad Dermatol Venereol. 2005;19:672-88.
- [CrossRef] [PubMed] [Google Scholar]
- Emollients and moisturizers for eczema: Abridged Cochrane systematic review including GRADE assessments. Br J Dermatol. 2017;177:1256-71.
- [CrossRef] [PubMed] [Google Scholar]
- Contact dermatitis: a practice parameter. Ann Allergy Asthma Immunol. 2006;97:S1-38.
- [CrossRef] [Google Scholar]
- Moisturizers for the treatment of inflammatory skin conditions. J Drugs Dermatol. 2008;7:1038-43.
- [Google Scholar]
- Efficacy of the addition of salicylic acid to clindamycin and benzoyl peroxide combination for acne vulgaris. J Dermatol. 2012;39:433-8.
- [CrossRef] [PubMed] [Google Scholar]
- Moisturizers: Function, formulation and clinical applications In: Draelos Z, Dover JS, Alam M, eds. Cosmeceuticals (2nd ed). China: Saunders Elsevier; 2009. p. :97-102.
- [Google Scholar]
- Acne cosmeceutical myths In: Draelos Z, Dover JS, Alam M, eds. Cosmeceuticals (2nd ed). China: Saunders Elsevier; 2009. p. :179-81.
- [Google Scholar]
- Congenital ichthyosis: An overview of current and emerging therapies. Acta Derm Venereol. 2008;88:4-14.
- [CrossRef] [PubMed] [Google Scholar]
- Treatment of ichthyosis-there is always something you can do! In memoriam: Wolfgang Küster. J Am Acad Dermatol. 2007;57:542-7.
- [CrossRef] [Google Scholar]
- Management of ichthyosis in infants and children. Clin Dermatol. 2003;21:325-8.
- [CrossRef] [PubMed] [Google Scholar]
- Bioactive: A new era of bioactive ingredients in topical formulations for inflammatory dermatoses. Dermatol Ther. 2019;32:e13101.
- [CrossRef] [Google Scholar]
- Aloe Vera in dermatology: A brief review. G Ital Dermatol Venereol. 2009;144:85-91.
- [Google Scholar]
- Herbal treatment for dermatologic disorders In: Benzie IF, Wachtel-Galor S, eds. Herbal Medicine: Biomolecular and Clinical Aspects (2nd ed). Florida: Boca Raton; 2011. p. :97-210.
- [CrossRef] [Google Scholar]
- Anti-inflammatory and chemopreventive effects of triterpene cinnamates and acetates from shea fat. J Oleo Sci. 2010;59:273-80.
- [CrossRef] [PubMed] [Google Scholar]
- 18ß-glycyrrhetinic acid from licorice root impairs dendritic cells maturation and Th1 immune responses. Immunopharmacol Immunotoxicol. 2013;35:329-35.
- [CrossRef] [PubMed] [Google Scholar]
- The skin microbiome: Associations between altered microbial communities and disease. Australas J Dermatol. 2015;56:268-74.
- [CrossRef] [PubMed] [Google Scholar]
- Probiotics and atopic dermatitis: An overview. Front Microbiol. 2016;7:507.
- [CrossRef] [PubMed] [Google Scholar]
- Novel bioactive from Lactobacillus brevis DSM17250 to stimulate the growth of Staphylococcus epidermidis: A pilot study. Benef Microbes. 2017;8:121-31.
- [CrossRef] [PubMed] [Google Scholar]
- Effect of emollients containing vegetable-derived Lactobacillus in the treatment of atopic dermatitis symptoms: Split-body clinical trial. Ann Dermatol. 2014;26:150-5.
- [CrossRef] [PubMed] [Google Scholar]
- Effect of the lactic acid bacterium Streptococcus thermophilus on stratum corneum ceramide levels and signs and symptoms of atopic dermatitis patients. Exp Dermatol. 2003;12:615-20.
- [CrossRef] [PubMed] [Google Scholar]
- Moisturizers: The slippery road. Indian J Dermatol. 2016;61:279-87.
- [CrossRef] [PubMed] [Google Scholar]
